EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of a Combined Vitamin D3 and Docosahexaenoic Acid Intervention on Cognitive Function and Blood Pyroptotic Biomarkers in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized, Double-Blind, Placebo-Controlled Trial

Jing Yuan iD, Ruifang Yang iD, Hui Chen iD, Huichao Zhao iD, Xuan Chen iD, Ziyan Lou iD, Xinze Han iD, Fei Ma

Nutrients · 2026

DOI: 10.3390/nu18172777 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Jing Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin 300070, China. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Cholecalciferol, Cognitive Dysfunction, Cognition. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to assess the effects of a combined vitamin D3 (VD3) and docosahexaenoic acid (DHA) intervention on cognitive function and blood pyroptotic biomarkers in older adults with mild cognitive impairment (MCI).

Methods

In total, 360 participants with MCI were recruited, and randomly assigned into four groups: VD3 (800 IU/day), DHA (1 g/day), VD3+DHA (VD3 800 IU/day+DHA 1 g/day), and placebo. Cognitive function was evaluated by the Wechsler Adult Intelligence Scale-Revised in China (WAIS-RC), and blood biomarkers were measured by ELISA and Western blot at baseline, 6 months and 12 months. Linear mixed-effects models (LMMs) were employed to analyze longitudinal interaction effects on cognitive function and blood biomarkers. Structural equation modeling (SEM) was conducted to evaluate the parallel mediation effects of blood biomarkers on cognitive improvements.

Results

A total of 355 participants completed the trial. Over the 12-month intervention, all intervention groups demonstrated significant improvements in cognitive function and reductions in five blood biomarkers (IL-1β, IL-18, NLRP3, Gasdermin D (GSDMD), cleaved caspase-1) compared to the placebo group (p < 0.05). Compared to each single intervention, the combined VD3 and DHA intervention yielded superior cognitive improvements in scores for full-scale IQ (FIQ), performance IQ (PIQ), verbal IQ (VIQ) and several subtests (information, comprehension, digit span, vocabulary, picture completion, block design, and picture arrangement), and significantly reduced five blood pyroptotic biomarkers (all p < 0.05). Path analysis revealed that longitudinal GSDMD reduction mediated the improvements in FIQ.

Conclusions

A 12-month intervention with VD3, DHA, or their combination significantly improves cognitive function and mitigates pyroptosis, and the combined intervention showed superior benefits, potentially mediated by downregulating the protein GSDMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Docosahexaenoic AcidsCholecalciferolCognitive DysfunctionCognitionHumansMaleBiomarkersDouble-Blind MethodFemaleAgedDietary SupplementsCognitive EnhancementNLR Family, Pyrin Domain-Containing 3 ProteinInterleukin-1betaInterleukin-18

Stichwörter der Autor:innen

NLRP3 inflammasomedocosahexaenoic acidmild cognitive impairmentpyroptosisrandomized controlled trialvitamin D3

Substanzen

Docosahexaenoic AcidsCholecalciferolBiomarkersNLR Family, Pyrin Domain-Containing 3 ProteinInterleukin-1betaInterleukin-18

Autor:innen und Institutionen

  • Department of Epidemiology and Statistics, School of Public Health, Tianjin Medical University, Tianjin 300070, China.
  • Department of Obstetric, Gynecologic and Pediatric Nursing, School of Nursing, Tianjin Medical University, Tianjin 300070, China.
  • Department of Medicine and Humanities, School of Marxism, Tianjin Medical University, Tianjin 300070, China.

ORCID-Profile: Jing Yuan, Ruifang Yang, Hui Chen, Huichao Zhao, Xuan Chen, Ziyan Lou, Xinze Han

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yuan, J., Yang, R., Chen, H., Zhao, H., Chen, X., Lou, Z., Han, X., & Ma, F. (2026). Effects of a Combined Vitamin D3 and Docosahexaenoic Acid Intervention on Cognitive Function and Blood Pyroptotic Biomarkers in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu18172777

Vancouver

Yuan J, Yang R, Chen H, Zhao H, Chen X, Lou Z, et al. Effects of a Combined Vitamin D3 and Docosahexaenoic Acid Intervention on Cognitive Function and Blood Pyroptotic Biomarkers in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2026. doi:10.3390/nu18172777

BibTeX
@article{Yuan2026,
  author = {Yuan, Jing and Yang, Ruifang and Chen, Hui and Zhao, Huichao and Chen, Xuan and Lou, Ziyan and Han, Xinze and Ma, Fei},
  title = {Effects of a Combined Vitamin D3 and Docosahexaenoic Acid Intervention on Cognitive Function and Blood Pyroptotic Biomarkers in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized, Double-Blind, Placebo-Controlled Trial},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18172777}
}
Kostenlos starten →